U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07940036) titled 'Skin Cancer Detection in Primary Care With and Without DermaSensor' on Nov. 02.
Brief Summary: This randomized controlled trial evaluates whether primary care physician access to the DermaSensor device increases the proportion of patients with histopathology-confirmed skin cancer compared with physician standard clinical assessment alone. Participating physicians are randomized and outcomes are drawn from existing electronic health record data for up to 500,000 patient encounters.
Study Start Date: Nov. 10
Study Type: INTERVENTIONAL
Condition:
Skin Cancer
Basal Cell Cancer
Squamous Cell Carcinoma
Melanoma (Skin Cancer)
Melanoma ...